For research use only. Not for use in humans.

Zagotenemab (Anti-Tau)

Synonyms: LY33003560

Zagotenemab (Anti-Tau) is a humanised anti-tau antibody that selectively binds and neutralises tau deposits in the brain. It has the potential to be used in Alzheimer's disease research. MW : 145.5 KD

Zagotenemab (Anti-Tau)

Quality Control

Batch: A234101 Purity: 99% Protein concentration: 11.36mg/ml Endotoxin Level: <1EU/mg
99

Specificity

Name Citation Microtubule Associated Microtubule Associated  Others
Patupilone (Epothilone B) 17
Plinabulin 5
Lexibulin (CYT997) 8
Epothilone A 6
CW069 8
RMC-4630 0
Parbendazole 0
Combretastatin A4 7
CK-636 5
ABT-751 (E7010) 5
Nocodazole 130 Abl,Abl (E255K),Abl (T315I)
T-1101 tosylate 0
iHAP1 1
Trigonelline 3 Akt,PI3K,PLCγ1
Myoseverin 0
Indibulin 1
EGFR Inhibitor 3 EGFR
MMAF 1
DM1 (Mertansine) 1
SSE15206 0
ELR-510444 0
TAI-1 2
INH6 0
INH1 2
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Zagotenemab (Anti-Tau) is a humanised anti-tau antibody that selectively binds and neutralises tau deposits in the brain. It has the potential to be used in Alzheimer's disease research. MW : 145.5 KD

Product Details

CAS No. 2019133-28-7
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.